Trastuzumab Deruxtecan in HER2-Low Breast Cancer. Carroll HK, Higgins MJ, O'Reilly S. N Engl J Med 2022;387:1144.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Carroll HK, Higgins MJ, O'Reilly S. Trastuzumab Deruxtecan in HER2-Low Breast Cancer. N Engl J Med 2022;387:1144.
PMID: 36130005